Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PALI Palisade Bio > Detailed Quotes

PALI Palisade Bio

Watchlist
4.010
-0.230-5.42%
Close  12/05 16:00 ET
4.120
+0.110+2.74%
Post Mkt Price 12/05 19:49 ET
High
4.450
Open
4.330
Turnover
1.32M
Low
3.940
Pre Close
4.240
Volume
314.89K
Market Cap
6.18M
P/E(TTM)
Loss
52wk High
105.000
Shares
1.54M
P/E(Static)
Loss
52wk Low
2.040
Float Cap
5.16M
Bid/Ask %
66.67%
Historical High
39600.000
Shs Float
1.29M
Volume Ratio
0.30
Historical Low
2.040
Dividend TTM
--
Div Yield TTM
--
P/B
0.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
24.45%
Amplitude
12.03%
Avg Price
4.206
Lot Size
1
Float Cap
5.16M
Bid/Ask %
66.67%
Historical High
39600.000
Shs Float
1.29M
Volume Ratio
0.30
Historical Low
2.040
Dividend TTM
--
P/B
0.50
Dividend LFY
--
Turnover Ratio
24.45%
Amplitude
12.03%
Avg Price
4.206
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
CEO: Mr. J. D. Finley
Market: NASDAQ
Listing Date: 08/27/2007
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist